Interpharm Holdings, Inc.
IPAH
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Revenue | -7.24% | -22.39% | -6.76% | 23.59% | 7.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.24% | -22.39% | -6.76% | 23.59% | 7.81% |
| Cost of Revenue | 3.73% | 20.14% | 7.14% | 11.76% | 21.63% |
| Gross Profit | -43.78% | -88.01% | -46.57% | 59.41% | -21.80% |
| SG&A Expenses | 6.04% | 42.07% | 3.45% | 19.41% | 41.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.96% | 19.80% | 16.91% | 20.67% | 41.56% |
| Operating Income | 0.33% | -311.99% | -148.40% | 0.13% | -467.44% |
| Income Before Tax | 18.42% | -363.61% | -136.11% | -7.13% | -722.50% |
| Income Tax Expenses | 413.21% | -- | 313.07% | 19.44% | -630.00% |
| Earnings from Continuing Operations | -164.23% | -523.07% | -295.72% | -23.55% | -777.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -164.23% | -523.07% | -295.72% | -23.55% | -777.18% |
| EBIT | 0.33% | -311.99% | -148.40% | 0.13% | -467.44% |
| EBITDA | 11.69% | -254.19% | -165.25% | 10.59% | -342.25% |
| EPS Basic | -204.41% | -2,857.89% | -88.41% | 28.25% | -520.96% |
| Normalized Basic EPS | -11.35% | -357.31% | -73.18% | 48.82% | -321.39% |
| EPS Diluted | -204.41% | -3,011.11% | -91.34% | 28.25% | -936.90% |
| Normalized Diluted EPS | -11.35% | -370.12% | -73.18% | 48.82% | -560.00% |
| Average Basic Shares Outstanding | 2.57% | 2.28% | 34.82% | 101.39% | 100.42% |
| Average Diluted Shares Outstanding | 2.57% | -2.45% | 34.82% | 101.39% | -3.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 1.00% | -- | -1.11% |